Thousands of plaintiffs have sued, alleging that J&J's baby powder & other talc products sometimes contained asbestos and caused ovarian cancer & mesothelioma.
New Delhi: The Indian Patent Office had held its final hearing on a challenge filed by two tuberculosis survivors to prevent the Indian arm of drugmaker Johnson & Johnson from extending its patent on bedaquiline, used against drug-resistant TB, beyond the primary patent’s expiry in July
The health conglomerate, which maintains the product is safe, has for almost a decade faced lawsuits accusing it of hiding cancer risks tied to its talc-based baby powder. The company had earlier dropped its legacy tac-based baby powder-from the US and Canada in 2020 as the lawsuits piled on.